Federation des caisses Desjardins du Quebec’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.1K Sell
9,500
-2,500
-21% -$9.52K ﹤0.01% 1970
2025
Q4
$41.6K Sell
12,000
-3,900
-25% -$17.3K ﹤0.01% 1865
2025
Q3
$88.1K Sell
15,900
-5,300
-25% -$21.5K ﹤0.01% 1662
2025
Q2
$52.4K Buy
+21,200
New +$32.7K ﹤0.01% 1549

Other funds holding PRME

Federation des caisses Desjardins du Quebec's PRME Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec reduced its Prime Medicine (PRME) stake by 21% in Q1 2026, selling an estimated $9.52K and leaving 9,500 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Federation des caisses Desjardins du Quebec first reported a position in PRME in Q2 2025 and has held it in 4 quarters since. The position peaked at $88.1K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 9,500 shares of Prime Medicine worth $33.1K as of Q1 2026.
  • Federation des caisses Desjardins du Quebec sold 2,500 Prime Medicine shares in Q1 2026, an estimated $9.52K.
  • Prime Medicine made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #1970 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Prime Medicine in Q2 2025 and has held it in 4 quarters since.
  • Federation des caisses Desjardins du Quebec's Prime Medicine position peaked at $88.1K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.